Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -347,694 | -236,642 | -148,119 | -72,495 | -52,769 |
| Depreciation Amortization | 310 | -135 | 1,258 | 1,883 | 948 |
| Accounts receivable | -23,196 | 198 | 3,164 | N/A | -3,414 |
| Accounts payable and accrued liabilities | 1,448 | -445 | 1,532 | 4 | 1,391 |
| Other Working Capital | 9,725 | 31,240 | 14,441 | 39,886 | 14,411 |
| Other Operating Activity | 81,392 | 30,775 | 7,859 | 6,209 | 7,757 |
| Operating Cash Flow | $-278,015 | $-175,009 | $-119,865 | $-24,513 | $-31,676 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,453 | -148,411 | -56,835 | -216,467 | N/A |
| PPE Investments | -14,013 | -12,677 | -15,512 | -2,354 | -4,883 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,196 |
| Investing Cash Flow | $-16,466 | $-161,088 | $-72,347 | $-218,821 | $-6,079 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -1,528 | -2,583 | -3,333 | -1,806 |
| Common Stock Issued | 340,754 | 6,425 | 547,496 | 136,053 | 157,074 |
| Other Financing Activity | -116 | -443 | -965 | -143 | -2,046 |
| Financing Cash Flow | $340,638 | $4,454 | $543,948 | $132,577 | $153,222 |
| Exchange Rate Effect | 18 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 73,429 | 405,072 | 53,336 | 164,093 | 47,240 |
| End Cash Position | 119,604 | 73,429 | 405,072 | 53,336 | 162,707 |
| Net Cash Flow | $46,175 | $-331,643 | $351,736 | $-110,757 | $115,467 |
| Free Cash Flow | |||||
| Operating Cash Flow | -278,015 | -175,009 | -119,865 | -24,513 | -31,676 |
| Capital Expenditure | -14,013 | -12,677 | -15,512 | -2,354 | -4,883 |
| Free Cash Flow | -292,028 | -187,686 | -135,377 | -26,867 | -36,559 |